{"id":34,"date":"2019-04-02T16:01:28","date_gmt":"2019-04-02T16:01:28","guid":{"rendered":"http:\/\/f0c1857d78.nxcli.net\/tumor\/?page_id=34"},"modified":"2019-04-02T16:01:28","modified_gmt":"2019-04-02T16:01:28","slug":"tumor-section-spring-2019","status":"publish","type":"page","link":"https:\/\/newsletters.aans.org\/tumor\/tumor-section-spring-2019\/","title":{"rendered":"Tumor Section Spring 2019"},"content":{"rendered":"\n\n
\n

From the Chair<\/a><\/h3>
Greetings, and Welcome to the Spring 2019 AANS\/CNS Section on Tumors Newsletter \r\nDear Colleagues:\r\n\r\nAs we look forward to gathering again at the 2019 AANS Annual Scientific Meeting in San Diego, this is a great opportunity to reflect upon recent accomplishments...<\/div><\/div>\n

Brain Tumor Resection Using 5-ALA<\/a><\/h3>
As of June 2017, 5-ALA is approved for use by the FDA as an intraoperative optical imaging agent for the visualization of suspected World Health Organization (WHO) grade III or IV high-grade gliomas (HGGs). With the U.S. commercial launch of 5-ALA in...<\/div><\/div>\n

Historian Report<\/a><\/h3>
The AANS\/CNS Section on Tumors experienced great success during the 13th Tumor Section Satellite Symposium and 2019 CNS Annual Meeting. \r\nThe 13th Tumor Section Satellite Symposium was held for the first time in Houston, October 5-6, 2018. The meeting...<\/div><\/div>\n

Awards Update<\/a><\/h3>
The Tumor Section Awards Committee continues to develop the most robust award program for outstanding research of any of the AANS\/CNS sections. Each year, we give 12 awards, plus one named lectureship at the AANS Annual Scientific Meeting and nine awards,...<\/div><\/div>\n

Fellowship Award Update<\/a><\/h3>
The AANS\/CNS Section on Tumors takes great pride in supporting and encouraging young investigators to innovate the field of neuro-oncology with bench research.\r\n\r\nIn 2018, the AANS\/CNS Section on Tumor started a new research fellowship award in collaboration...<\/div><\/div>\n

2019 AANS Annual Scientific Meeting Preview<\/a><\/h3>
The tumor sessions at the 2019 AANS Annual Scientific Meeting are only a few weeks away. We are excited that Linda Liau, MD, PhD, MBA, FAANS, has agreed to headline our first scientific session as the 2019 Bittner lecturer. We anticipate her talk will...<\/div><\/div>\n

CNS 2019 Meeting Preview<\/a><\/h3>
The 2019 CNS Annual Meeting is coming October 19-23, and the Tumor Section has been designing an exciting and informative program with varied formats. Leading up to the main meeting sessions, we have several technique and technology oriented courses on...<\/div><\/div>\n

CNS 2018 Recap<\/a><\/h3>
Thank you for those who attended the 2018 Annual Meeting of the Congress of Neurological Surgeons Section on Tumors sessions.\r\n\r\nTo recap, the meeting supplied a rich program highlighting the advances in the diagnosis and treatment of oncological disorders...<\/div><\/div>\n

NASBS 2019 Recap<\/a><\/h3>
The 29th Annual Meeting of the North American Skull Base Society (NASBS) was held February 15-17, 2019, at the Hilton Bonnet Creek Hotel in Orlando, Fla. The meeting welcomed 766 registrants from 38 countries and featured scientific sessions on the latest...<\/div><\/div>\n

Clinical Trial Highlight: NRG-BN003<\/a><\/h3>
NRG-BN003, a Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma \r\nNRG-BN003 is for patients with World Health Organization (WHO) grade II (atypical) meningiomas that have received gross-total resection (GTR)....<\/div><\/div>\n

Clinical Trials in the Adult Brain Tumor Consortium<\/a><\/h3>
ABTC 1603: Phase I Study of Neoadjuvant GMCI + PD-1 Inhibitor Combined with Standard of Care for Newly Diagnosed High-Grade Gliomas PI: Nino Chiocca, MD, PhD, FAANS The hypothesis of this study is combining Gene Modified Cytotoxic Immunotherapy (GMCI)...<\/div><\/div>\n

The Alliance for Clinical Trials in Neuro-Oncology<\/a><\/h3>
About the Alliance for Clinical Trials in Oncology \r\nThe AANS\/CNS Tumor Section has implemented a collaboration with the Alliance for Clinical Trials in Oncology to facilitate cooperative efforts between neurosurgeons, neuro-oncologists and radiation...<\/div><\/div>\n

Journal of Neuro-Oncology<\/a><\/h3>
\r\n\r\nThe Journal of Neuro-Oncology (JNO) is the official journal of the AANS and CNS Tumor Section. Nine other prominent organizations also help to sponsor the journal. The latest organization to sponsor the JNO is the Radiosurgery Society (RSS) and...<\/div><\/div>\n

International Report Summary<\/a><\/h3>
\r\n\r\nAs the first awardee of the International Observership Program, I had the fantastic opportunity to participate in the brain tumor program at the University of Miami, directed by Ricardo Komotar, MD, FAANS, and Michael Ivan, MD. The observership, sponsored...<\/div><\/div>\n

SNOSSA Report<\/a><\/h3>
The 2nd Annual Meeting of the Society for Neuro-Oncology of Sub-Saharan Africa (SNOSSA) http:\/\/www.snossa.org\/ will be hosted in conjunction with the South African Paediatric Brain Tumour Workshop (PBTW) at the University of Cape Town, August 7-8, 2019.\r\n\r\nThe...<\/div><\/div>\n

AANS\/NREF and ASTRO National SRS Registry Update<\/a><\/h3>
The AANS\/NREF and ASTRO National Stereotactic Radiosurgery Quality Registry is a joint venture of organized neurosurgery and radiation oncology to define national patterns of care in radiosurgery. The goals are to identify gaps in treatment quality, measure...<\/div><\/div>\n

Young Neurosurgeons Reception - CNS 2018<\/a><\/h3>
\r\n\r\nHouston \u2013 Nelson Oyesiku, MD, PhD, FAANS, professor at Emory University and past president of the Congress of Neurological Surgeons (CNS), was the honored guest at the AANS\/CNS Section on Tumors Young Neurosurgeons Reception, co-hosted by the Young N...<\/div><\/div>\n

Guidelines<\/a><\/h3>
The update to the CNS\/AANS-sponsored Guidelines for the Management of Brain Metastases , led by the Tumor Section and initially published in 2010, is published electronically as of January 2019 and in hard copy (Neurosurgery ) in March 2019. This is...<\/div><\/div>\n

International Neurosurgery in the Developing World<\/a><\/h3>
Since 2012, Jack Rock, MD, FAANS, under the auspices of the Foundation for International Education in Neurosurgery (FIENS), has traveled to Yangon, Myanmar, yearly in support of the neurosurgery training program at Yangon General Hospital and, more recently,...<\/div><\/div>\n

Washington Committee Update Spring 2019<\/a><\/h3>
Neurosurgeons who focus on oncology face the same daily challenges that all neurosurgeons experience, including regulatory burdens such as prior authorization and mandates to utilize appropriate use criteria (AUC). Whether ordering imaging for tumor surveillance,...<\/div><\/div>\n\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"NewsletterTOC.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-34","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nTumor Section Spring 2019 - Tumor News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/newsletters.aans.org\/tumor\/tumor-section-spring-2019\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tumor Section Spring 2019 - Tumor News\" \/>\n<meta property=\"og:url\" content=\"https:\/\/newsletters.aans.org\/tumor\/tumor-section-spring-2019\/\" \/>\n<meta property=\"og:site_name\" content=\"Tumor News\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/tumor-section-spring-2019\\\/\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/tumor-section-spring-2019\\\/\",\"name\":\"Tumor Section Spring 2019 - Tumor News\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#website\"},\"datePublished\":\"2019-04-02T16:01:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/tumor-section-spring-2019\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/tumor-section-spring-2019\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/tumor-section-spring-2019\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tumor Section Spring 2019\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#website\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/\",\"name\":\"Tumor News\",\"description\":\"Just another AANS Newsletter Sites site\",\"publisher\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#organization\",\"name\":\"Tumor News\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/newsletters.aans.org\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2024\\\/11\\\/JST.2024.logo_.png\",\"contentUrl\":\"https:\\\/\\\/newsletters.aans.org\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2024\\\/11\\\/JST.2024.logo_.png\",\"width\":2336,\"height\":2294,\"caption\":\"Tumor News\"},\"image\":{\"@id\":\"https:\\\/\\\/newsletters.aans.org\\\/tumor\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tumor Section Spring 2019 - Tumor News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/newsletters.aans.org\/tumor\/tumor-section-spring-2019\/","og_locale":"en_US","og_type":"article","og_title":"Tumor Section Spring 2019 - Tumor News","og_url":"https:\/\/newsletters.aans.org\/tumor\/tumor-section-spring-2019\/","og_site_name":"Tumor News","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/newsletters.aans.org\/tumor\/tumor-section-spring-2019\/","url":"https:\/\/newsletters.aans.org\/tumor\/tumor-section-spring-2019\/","name":"Tumor Section Spring 2019 - Tumor News","isPartOf":{"@id":"https:\/\/newsletters.aans.org\/tumor\/#website"},"datePublished":"2019-04-02T16:01:28+00:00","breadcrumb":{"@id":"https:\/\/newsletters.aans.org\/tumor\/tumor-section-spring-2019\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/newsletters.aans.org\/tumor\/tumor-section-spring-2019\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/newsletters.aans.org\/tumor\/tumor-section-spring-2019\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/newsletters.aans.org\/tumor\/"},{"@type":"ListItem","position":2,"name":"Tumor Section Spring 2019"}]},{"@type":"WebSite","@id":"https:\/\/newsletters.aans.org\/tumor\/#website","url":"https:\/\/newsletters.aans.org\/tumor\/","name":"Tumor News","description":"Just another AANS Newsletter Sites site","publisher":{"@id":"https:\/\/newsletters.aans.org\/tumor\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/newsletters.aans.org\/tumor\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/newsletters.aans.org\/tumor\/#organization","name":"Tumor News","url":"https:\/\/newsletters.aans.org\/tumor\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/newsletters.aans.org\/tumor\/#\/schema\/logo\/image\/","url":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2024\/11\/JST.2024.logo_.png","contentUrl":"https:\/\/newsletters.aans.org\/wp-content\/uploads\/sites\/5\/2024\/11\/JST.2024.logo_.png","width":2336,"height":2294,"caption":"Tumor News"},"image":{"@id":"https:\/\/newsletters.aans.org\/tumor\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages\/34","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/comments?post=34"}],"version-history":[{"count":1,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages\/34\/revisions"}],"predecessor-version":[{"id":77,"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/pages\/34\/revisions\/77"}],"wp:attachment":[{"href":"https:\/\/newsletters.aans.org\/tumor\/wp-json\/wp\/v2\/media?parent=34"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}